The Qinghai Province Science and Technology Department disclosed on July 2 that the province has built an integrated innovation platform for the efficient use of biological resources of the Qinghai-Tibet Plateau. The platform will promote an upgrade to the standard for biological resources, Tibetan medicinal materials, and related pharmaceuticals in Qinghai Province and will solve key and common professional issues.

Known as the world's "Third Pole", the Qinghai-Tibet Plateau is the most concentrated area of biodiversity of high-altitude regions in the world.

According to the Qinghai Province Science and Technology Department, the platform took three years to build. It integrates technological development, product research and development, pilot testing, achievement transformation, and industrial services.

The building of the platform is led by the Chinese Academy of Social Sciences Northwest Plateau Institute of Biology. They have built one production line of high-altitude characteristic resources products and served 13 enterprises, transforming more than 10 new products and science and technology achievements and creating 186 million yuan (27 million US dollars) in economic benefits for businesses.

Qinghai is the main area for developing Tibetan medicine in China. There are currently 19 Tibetan medicinal production businesses in Qinghai. In 2018, the total output value of Qinghai's Tibetan medicine industry reached 2.6 billion yuan (0.38 billion US dollars), accounting for 44 percent of the total output value of China's Tibetan medicine industry. The scale of development and comprehensive strength of Qinghai's Tibetan medicine industry ranks first in China.

Editor: Tommy Tan.